SouthState Corp’s Ocugen OCGN Stock Holding History

SouthState Corp’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,000	Closed	-$5.63K	–	1726
2024 Q4	$5.63K	Hold	7,000	–	–	﹤0.01%	559
2024 Q3	$6.95K	Hold	7,000	–	–	﹤0.01%	504
2024 Q2	$10.8K	Hold	7,000	–	–	﹤0.01%	483
2024 Q1	$11.5K	Buy	+7,000	New	+$5.87K	﹤0.01%	492

Other funds holding OCGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Rinkey Investments San Diego, California $425M AUM 14.99% 1-Year Est. Return

SouthState Corp's OCGN Position: Q1 2025 in Review

SouthState Corp sold out of Ocugen (OCGN) in Q1 2025, closing a stake of 7,000 shares — an estimated $5.63K sold.

SouthState Corp first reported a position in OCGN in Q1 2024 and held it in 4 quarters. The position peaked at $11.5K in Q1 2024. 110 funds tracked by Wall St. Rank hold OCGN as of Q1 2025.

SouthState Corp reported no remaining Ocugen position as of Q1 2025 after selling out during the quarter.
SouthState Corp sold 7,000 Ocugen shares in Q1 2025, an estimated $5.63K.
SouthState Corp first reported a position in Ocugen in Q1 2024 and held it in 4 quarters.
SouthState Corp's Ocugen position peaked at $11.5K in Q1 2024.
110 funds tracked by Wall St. Rank held Ocugen as of Q1 2025.

Based on SouthState Corp's 13F filing for Q1 2025, filed 12 May 2025.